The EFCAB10 (EF-hand calcium-binding domain-containing protein 10) antibody is a tool used to study the poorly characterized protein EFCAB10. which belongs to the EF-hand calcium-binding protein family. These proteins typically regulate calcium-dependent signaling pathways, influencing cellular processes like proliferation, differentiation, and apoptosis. EFCAB10 contains multiple EF-hand motifs, suggesting its potential role in calcium sensing or buffering, though its exact physiological functions remain unclear. Current research links EFCAB10 to diverse biological contexts, including cancer, neurodegenerative disorders, and cardiovascular diseases, where calcium signaling dysregulation is often implicated. The antibody enables detection of EFCAB10 expression and localization in tissues or cell lines via techniques like Western blotting, immunohistochemistry, or immunofluorescence. Recent studies highlight its possible involvement in cellular stress responses and mitochondrial function, warranting further exploration. However, limited literature and incomplete functional annotation pose challenges in defining its mechanistic roles. Commercial EFCAB10 antibodies are often validated for specificity, aiding researchers in mapping its tissue distribution and interaction networks. Ongoing work aims to clarify its contribution to disease pathways and assess its potential as a therapeutic target or biomarker.